Risk of de novo posterior vaginal prolapse after anterior laparoscopic sacrocolpopexy: Evaluation at one year.


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 06 01 2020
revised: 24 04 2020
accepted: 29 04 2020
pubmed: 29 5 2020
medline: 29 6 2021
entrez: 29 5 2020
Statut: ppublish

Résumé

Treatment of anterior vaginal and/or apical prolapse by sacrocolpopexy is most often performed by systematic placement of two non-resorbable meshes, anterior and posterior, whether or not there is an associated posterior vaginal prolapse. We believe that isolated correction of an anterior vaginal and/or apical prolapse in the absence of posterior vaginal prolapse is not associated with a higher rate of de novo posterior vaginal prolapse. A prospective, observational, monocenter study performed in the Gynecology unit of the Conception UHC in Marseille from May 2011 to October 2014. Patients over 18 years of age exhibiting an anterior vaginal and/or apical prolapse of stage ≥ 2 of the POP-Q classification resulting in functional impairment with alteration of the quality of life, without an associated posterior vaginal prolapse were included and underwent a laparoscopic anterior sacrocolpopexy (ASP). They were seen again in consultation one year from the intervention. Validated quality of life questionnaires were completed pre- and one year postoperatively. 50 patients were included. The rate of de novo posterior vaginal prolapse was 8/50 (16 %). At one year, there was a significant improvement in terms of the SPDI-20 and SPIQ-7 (p < 0.0001) questionnaire, without significant improvement in the quality of sexual function (PISQ-12 questionnaire) (p = 0.073). The risk of de novo posterior vaginal prolapse at one year is low when an ASP is carried out.

Identifiants

pubmed: 32461070
pii: S2468-7847(20)30142-2
doi: 10.1016/j.jogoh.2020.101799
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

101799

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

Myriam Toumi (M)

Gynecology-Obstetrics Unit, Conception Hospital, 147, Boulevard Baille. 13005, Marseille, France. Electronic address: toumi.myriam@gmail.com.

Claire Tourette (C)

Gynecology-Obstetrics Unit, Conception Hospital, 147, Boulevard Baille. 13005, Marseille, France. Electronic address: TOURETTE@ap-hm.fr.

Maxime Marcelli (M)

Gynecology-Obstetrics Unit, Saint-Joseph Hospital, 26 Boulevard de Louvain, 13008, Marseille, France. Electronic address: maximemarcelli@icloud.com.

Audrey Pivano (A)

Gynecology-Obstetrics Unit, Conception Hospital, 147, Boulevard Baille. 13005, Marseille, France. Electronic address: audrey-pivano@hotmail.fr.

Caroline Rambeaud (C)

Gynecology-Obstetrics Unit, Conception Hospital, 147, Boulevard Baille. 13005, Marseille, France. Electronic address: carorambeaud@hotmail.com.

Aubert Agostini (A)

Gynecology-Obstetrics Unit, Conception Hospital, 147, Boulevard Baille. 13005, Marseille, France. Electronic address: aubert.agostini@ap-hm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH